X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PIRAMAL ENTERPRISES UNICHEM LAB/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 22.6 38.2 59.0% View Chart
P/BV x 2.4 3.8 62.3% View Chart
Dividend Yield % 0.8 0.6 125.4%  

Financials

 UNICHEM LAB   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PIRAMAL ENTERPRISES
Mar-16
UNICHEM LAB/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3341,065 31.4%   
Low Rs174805 21.6%   
Sales per share (Unadj.) Rs146.9383.0 38.4%  
Earnings per share (Unadj.) Rs11.955.1 21.6%  
Cash flow per share (Unadj.) Rs16.274.1 21.9%  
Dividends per share (Unadj.) Rs2.0017.50 11.4%  
Dividend yield (eoy) %0.81.9 42.1%  
Book value per share (Unadj.) Rs105.1719.9 14.6%  
Shares outstanding (eoy) m90.84172.56 52.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.72.4 70.8%   
Avg P/E ratio x21.417.0 125.8%  
P/CF ratio (eoy) x15.712.6 124.3%  
Price / Book Value ratio x2.41.3 186.0%  
Dividend payout %16.831.8 52.9%   
Avg Mkt Cap Rs m23,073161,344 14.3%   
No. of employees `0005.73.8 150.0%   
Total wages/salary Rs m2,55816,898 15.1%   
Avg. sales/employee Rs Th2,352.517,472.6 13.5%   
Avg. wages/employee Rs Th450.94,466.9 10.1%   
Avg. net profit/employee Rs Th190.42,512.8 7.6%   
INCOME DATA
Net Sales Rs m13,34666,099 20.2%  
Other income Rs m1922,425 7.9%   
Total revenues Rs m13,53868,524 19.8%   
Gross profit Rs m1,63918,723 8.8%  
Depreciation Rs m3903,274 11.9%   
Interest Rs m299,388 0.3%   
Profit before tax Rs m1,4128,485 16.6%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m-41,593 -0.2%   
Extraordinary Inc (Exp) Rs m-35457 -7.7%   
Tax Rs m2931,032 28.4%   
Profit after tax Rs m1,0809,506 11.4%  
Gross profit margin %12.328.3 43.4%  
Effective tax rate %20.712.2 170.4%   
Net profit margin %8.114.4 56.3%  
BALANCE SHEET DATA
Current assets Rs m5,97947,488 12.6%   
Current liabilities Rs m2,432104,362 2.3%   
Net working cap to sales %26.6-86.0 -30.9%  
Current ratio x2.50.5 540.3%  
Inventory Days Days6341 155.3%  
Debtors Days Days6051 118.0%  
Net fixed assets Rs m6,40326,532 24.1%   
Share capital Rs m182345 52.7%   
"Free" reserves Rs m9,293114,024 8.1%   
Net worth Rs m9,548124,221 7.7%   
Long term debt Rs m23075,812 0.3%   
Total assets Rs m12,843308,356 4.2%  
Interest coverage x50.01.9 2,627.9%   
Debt to equity ratio x00.6 4.0%  
Sales to assets ratio x1.00.2 484.8%   
Return on assets %8.66.1 141.0%  
Return on equity %11.37.7 147.9%  
Return on capital %14.310.0 143.9%  
Exports to sales %29.217.2 170.0%   
Imports to sales %6.36.6 96.1%   
Exports (fob) Rs m3,90011,362 34.3%   
Imports (cif) Rs m8474,364 19.4%   
Fx inflow Rs m4,35614,435 30.2%   
Fx outflow Rs m1,1625,183 22.4%   
Net fx Rs m3,1949,253 34.5%   
CASH FLOW
From Operations Rs m1,119-67,773 -1.7%  
From Investments Rs m-853-8,768 9.7%  
From Financial Activity Rs m-33476,199 -0.4%  
Net Cashflow Rs m-68-342 19.9%  

Share Holding

Indian Promoters % 50.1 52.9 94.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.0 377.5%  
FIIs % 3.0 26.6 11.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 16.5 192.1%  
Shareholders   20,176 93,274 21.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  VENUS REMEDIES  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 16, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS